| Catalog No | Product Description | CAS No. | Purity | Structural Formula |
|---|---|---|---|---|
| SBP02918 |
Pellitorine
Pellitorine is a potential larvicide with a specific target site and a lead molecule for the control of mosquito populations, it also shows antiprotozoal activity against Plasmodium falciparum (IC50 = 3.3 ug/mL). Pellitorine shows potent antiplatelet aggregation activity, it can suppress expression of inducible NO synthase and cyclooxygenase-2. Pellitorine also shows strong cytotoxic activities against HL60 and MCT-7 cell lines. Pellitorine is a fatty amide. It has a role as a metabolite.
|
18836-52-7 | 98% |
|
| BP0999 |
N-Methylcytisine
N-Methylcytisine's nicotinic receptors have high affinity (KD = 50 nM)to nAChR from squid optical ganglia, N-methylcytisine is a selective ligand of nicotinic receptors of acetylcholine in the central nervous system. (−)-N-methylcytisine and (−)-anagyrine have nematicidal activity against pine wood nematodes.
|
486-86-2 | 98% |
|
| BP4108 |
Hydroxy-γ-sanshool
Hydroxy-gamma-sanshool is a fatty amide.
|
78886-66-5 | 98% |
|
| SBP02579 | 1897-26-3 |
|
||
| BP4110 |
Hydroxyl-γ-isosanshool
N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide is a fatty amide.
|
127514-62-9 | 98% |
|
| BPI026 | 42046-35-5 | 98% |
|
|
| BP0398 |
Corynoline
Corynoline is a benzophenanthridine alkaloid that is chelidonine substituted by a methyl group at position 13. Isolated from the aerial parts of Corydalis incisa, it acts as an acetylcholinesterase inhibitor and also exhibits antineoplastic and hepatoprotective activity. It has a role as a metabolite, an antineoplastic agent, an EC 3.1.1.7 (acetylcholinesterase) inhibitor and a hepatoprotective agent. Corynoline is a reversible and noncompetitive inhibitor of acetylcholinesterase(AChE) with the IC50 value of 30.6 microM, which exhibits the potent anti-inflammatory and/or immunosuppressive activity, the potent inhibitory activity of corynoline for the ICAM-1/LFA-1 adhesion and would be important on developing the clinically usable drugs for the inflammatory diseases.
|
18797-79-0 | 98% |
|
| BP4112 | 10076-00-3 |
|
||
| BP4863 | 70342-29-9 | 98% |
|
|
| SBP02251 | 64052-90-0 |
|
||
| SBP00071 | 110414-77-2 |
|
||
| BP0032 |
1-Monomyristin
1-Monomyristin is a 1-monoglyceride with tetradecanoyl (myristoyl) as the acyl group. It has a role as a Caenorhabditis elegans metabolite. It is a 1-monoglyceride and a tetradecanoate ester.
1-Monomyristin was extracted from Serenoa repens and inhibited the hydrolysis of 2-oleoyl glycerol (IC50=32 μ M) and the activity of fatty acid amide hydrolase (FAAH) (IC50=18 μ M). 1-Monomyristin has antibacterial activity against Staphylococcus aureus and actinomycetes, as well as antifungal activity against Candida albicans.
|
589-68-4 | 98% |
|
| BP4109 | 252193-26-3 |
|
||
| BP2202 | 1247014-34-1 | 98% |
|
|
| BPC0170 | 501-33-7 |
|
||
| SBP01548 | 1042143-83-8 |
|
||
| BP4739 |
Valerenic acid
Valerenic acid is a monocarboxylic acid that is 2-methylprop-2-enoic acid which is substituted at position 3 by a 3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl group. A bicyclic sesquiterpenoid constituent of the essential oil of the Valerian plant. It has a role as a volatile oil component, a sedative, a GABA modulator and a plant metabolite. It is a monocarboxylic acid, a sesquiterpenoid and a carbobicyclic compound. It is a conjugate acid of a valerenate. Valerenic acid, a subunit specific allosteric modulator of GABAA receptors, has anxiolytic, and antioxidant activities.
|
3569-10-6 | 98% |
|
| BP4111 | 504-97-2 |
|
||
| BP0049 |
(±)-Borneol
(±)-Borneol is a bornane monoterpenoid that is 1,7,7-trimethylbicyclo[2.2.1]heptane substituted by a hydroxy group at position 2. It has a role as a metabolite and a volatile oil component.(±)-Borneol is a bornane monoterpenoid that is 1,7,7-trimethylbicyclo[2.2.1]heptane substituted by a hydroxy group at position 2. It has a role as a metabolite and a volatile oil component.
(±)-Borneol is a bicyclic monoterpene used for analgesia and anaesthesia in traditional Chinese and Japanese medicine, it and its enantiomer (±)-Borneol have a highly efficacious positive modulating action at GABA(A) receptors at human recombinant alpha1beta2gamma2L GABA(A) receptors. Borneol specifically inhibits the nicotinic acetylcholine receptor (nAChR)-mediated effects in a noncompetitive way, can depress P-glycoprotein function by a NF-κB signaling mediated mechanism in a blood brain barrier in vitro model. Borneol has neuroprotection through the inhibition of IκBα-NF-κB and translocation signaling pathway, it also has an anti-cerebral ischemia effects. It can suppresse inflammatory responses in LPS-induced acute lung injury through inhibition of the NF-κB and MAPKs signaling pathways.
|
507-70-0 | 98% |
|
| BP1831 | 98% |
|
Shenshuai
Wenjing
Hedandan